News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Jun 19, 2007 Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price May 10, 2007 Insmed Incorporated Reports Financial Results for First Quarter Ended March 31, 2007 May 7, 2007 Insmed Announces First Quarter Earnings Release Date and Conference Call May 4, 2007 Insmed Raises Approximately $18.2 Million in Registered Direct Offering May 3, 2007 Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study May 2, 2007 Insmed CEO Geoffrey Allan Testifies at Energy and Commerce Committee Hearing Apr 30, 2007 Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study Apr 25, 2007 Insmed Inc. Releases Investor Fact Sheet with Updates on Drug Development Progress Mar 26, 2007 Insmed CEO Geoffrey Allan Testifies at Congressional Hearing Mar 16, 2007 Insmed Announces Additional Information In Compliance With NASDAQ Rules Show 5102550100 per page«1…48495051525354…69» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download